Enzo Biochem, Inc. (ENZ)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+13.55% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+13.55% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+65.89% vs
Rating Accuracy
100.0% (1 of 1*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+183.5%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+140.31%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+140.31%
FV Accuracy
14 Hits (32.56% Hit Rate)
FV Avg. Distance
+71.59%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Elazar Rabbani
Employees
500
Industry
-
Sector
-
Headquarters
New York
Exchange
New York Stock Exchange
Website
http://www.enzo.comSummary Stats
Market Cap
121M
Revenue
98.8M
Net Income
-26.6M
EPS
-$0.55
Price-to-Earnings
-4.45
Price-to-Book
2.68
Debt-to-Equity
0.89
News
Analyst Ratings
Price targets projected by 1 analyst
High
$5.00
Average
$5.50
Low
$5.00
Ratings calculated by 0 analysts
Buy
0
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q1 2023
Not Available
-$0.18 -
-
-0.04
Down 350%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--